Assessing The Health of Science Research

Editor's Note: Just as last week's presidential sweepstakes was entering its final stages, the United States House of Representatives' Committee on Science, Space, and Technology received a candid 19-page report from its chairman, George E. Brown, Jr. (D-Calif.). The report focused on a subject certain to exert major influence on the next administration, the legislators in office after January 1993, and the U.S. science community at large. The document--entitled "Report of the Task Force on the

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Editor's Note: Just as last week's presidential sweepstakes was entering its final stages, the United States House of Representatives' Committee on Science, Space, and Technology received a candid 19-page report from its chairman, George E. Brown, Jr. (D-Calif.). The report focused on a subject certain to exert major influence on the next administration, the legislators in office after January 1993, and the U.S. science community at large. The document--entitled "Report of the Task Force on the Health of Research"--was presented, Brown wrote in a letter of transmittal to his committee, in the belief that "it challenges us to create better linkages between the research that we authorize and the national goals that we seek." Following are excerpts from the report (ISBN 0-16-038862-7), the entirety of which is available from: U.S. Government Printing Office, Superintendent of Documents, Congressional Sales Office, Washington, D.C. 20402.

The U.S. system of scientific, engineering, and mathematical ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies